Pharma Focus Asia
KP - Sustainable Packaging Solutions

Upperton Pharma Solutions Plans to Open New Manufacturing Facility

Introduction:

Upperton Pharma Solutions plans to start the construction of new GMP manufacturing facility in Nottingham, UK.

Features:

The new state-of-the-art manufacturing and development facility covers an area of 50,000 square foot facility.

The newly constructed site will significantly increase the current capabilities in terms of capacity and production volume by increasing its size to ten new GMP manufacturing facilities, quality control laboratories and includes a dedicated analytical and formulation development laboratories consisting of pilot plants.

The Trent Gateway site consists the capability to handle a range of dosage forms including solids, liquids, semi-solids, nasal and inhaled products, and allows it to support early formulation development, by providing clinical trial supplies from Phase 1 to Phase 3 and niche-scale commercial manufacture.

The new facility is expected to be fully opearational by the end of 2024 and create 150 additional full-time jobs.

Specifications:

NameUpperton Pharma Solutions
TypeNew Construction
Year2024

 

Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelTFS - ODW - The Technology Debate: Single-Use vs. Stainless SteelAsia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 20244th Middle East Pharmacoeconomics and Drug Policy Summit 2024Digital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference
Searching for an end-to-end patient tech solution?